HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sosana Delimpasi Selected Research

Cyclophosphamide (Cytoxan)

1/2019Phase 2 study of all-oral ixazomib, cyclophosphamide and low-dose dexamethasone for relapsed/refractory multiple myeloma.
9/2015Dexamethasone, rituximab, and cyclophosphamide as primary treatment of Waldenström macroglobulinemia: final analysis of a phase 2 study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Sosana Delimpasi Research Topics

Disease

20Multiple Myeloma
06/2022 - 08/2010
3Pneumonia (Pneumonitis)
02/2022 - 11/2020
3Thrombocytopenia (Thrombopenia)
02/2022 - 11/2020
3Disease Progression
01/2022 - 09/2018
3Peripheral Nervous System Diseases (PNS Diseases)
10/2021 - 11/2020
2Neutropenia
02/2022 - 01/2021
2Waldenstrom Macroglobulinemia (Macroglobulinemia)
09/2015 - 06/2011
1COVID-19
02/2022
1Heart Failure
02/2022
1Myelodysplastic Syndromes (Myelodysplastic Syndrome)
02/2022
1Pancytopenia
02/2022
1Pain (Aches)
10/2021
1Frailty
01/2021
1Respiratory Tract Infections (Respiratory Tract Infection)
01/2021
1Fatigue
11/2020
1Hypercalcemia (Milk Alkali Syndrome)
11/2017
1Proteinuria
04/2014
1Bone Resorption
09/2012
1Monoclonal Gammopathy of Undetermined Significance
09/2012
1Bone Diseases (Bone Disease)
02/2012

Drug/Important Bio-Agent (IBA)

13Dexamethasone (Maxidex)FDA LinkGeneric
05/2022 - 09/2015
8Bortezomib (Velcade)FDA Link
01/2022 - 06/2011
6selinexorIBA
01/2022 - 11/2020
4daratumumabIBA
06/2022 - 01/2021
4Proteasome InhibitorsIBA
02/2022 - 11/2020
3Lenalidomide (CC 5013)FDA Link
02/2022 - 01/2021
3pomalidomideIBA
02/2022 - 01/2021
2carfilzomibIBA
05/2022 - 01/2021
2Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2019 - 09/2015
2Rituximab (Mabthera)FDA Link
09/2015 - 06/2011
1Biomarkers (Surrogate Marker)IBA
06/2022
1isatuximabIBA
05/2022
1melflufenIBA
02/2022
1Exportin 1 ProteinIBA
01/2021
1ixazomibIBA
01/2019
1CalciumIBA
11/2017
1Immunoglobulin D (IgD)IBA
04/2014
1CollagenIBA
09/2012
1collagen type I trimeric cross-linked peptideIBA
09/2012
1Alkaline PhosphataseIBA
09/2012
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
02/2012
1CytokinesIBA
02/2012
1Angiopoietin-2IBA
02/2012
1angiogeninIBA
02/2012
1Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA
02/2012
1Angiopoietin-1IBA
02/2012
1NucleosidesIBA
06/2011
1L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
08/2010

Therapy/Procedure

12Therapeutics
02/2022 - 02/2012